Show Us (the U.S.) the Savings
Reinke, T.
Managed Care 28(1): 9-10
2019
ISSN/ISBN: 1062-3388 PMID: 30883315 Document Number: 698911
Companies with originator biologics on the market have used a variety of regulatory and legal tricks to fend off biosimilars and keep the revenue generated by their products pouring in. The most common approach has been for the "originators" to take legal action to assert or defend the patents attached to their products.